Skip to main content
. 2022 Apr 25;13:855616. doi: 10.3389/fendo.2022.855616

Table 3.

Partial correlation of serum LCN-2 with other risk factors of DN and CAP.

Serum LCN-2 Serum LCN-2 (age-adjusted) Serum LCN-2 (age- and T2DM duration-adjusted)
Variables r P r P r P
Age 0.198 <0.001
T2DM duration 0.188 <0.001 0.133 <0.001
BMI -0.031 0.404 -0.019 0.598 -0.013 0.720
HbA1c* 0.047 0.201 0.108 0.003 0.106 <0.001
SBP 0.168 <0.001 0.115 0.002 0.099 0.004
DBP 0.016 0.672 0.022 0.545 0.027 0.007
TG* 0.029 0.428 0.064 0.081 0.066 0.458
TC* -0.041 0.260 -0.015 0.680 -0.016 0.072
HDL-c* -0.096 0.009 -0.140 <0.001 -0.147 0.667
LDL-c* -0.076 0.039 -0.055 0.134 -0.052 0.161
Sua* 0.056 0.124 0.074 0.044 0.069 0.060
Bun* 0.099 0.007 0.041 0.262 0.037 0.314
Scr* 0.187 <0.001 0.170 <0.001 0.161 <0.001
UACR* 0.260 <0.001 0.235 <0.001 0.201 <0.001
Hypertension 0.166 <0.001 0.099 0.007 0.091 0.013
Plaque score 0.399 <0.001 0.354 <0.001 0.347 <0.001
CAP 0.412 <0.001 0.370 <0.001 0.361 <0.001
DN 0.165 <0.001 0.140 <0.001 0.068 0.064

*Log transformed before analysis. The use of bold emphasis is to mark the statistically significant indicators.